Northwestern Mutual Wealth Management CO Eagle Pharmaceuticals, Inc. Transaction History

Northwestern Mutual Wealth Management CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$52.16 - $66.86 $1,877 - $2,406	-36 Closed	0 $0
Q4 2017 Jan 31, 2018	SELL	$49.6 - $60.87 $23,014 - $28,243	-464 Reduced 92.8%	36 $2,000
Q3 2017 Nov 07, 2017	BUY	$46.62 - $60.36 $23,310 - $30,180	500	500 $30,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $6.77M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.